tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

ARWR Stock Latest News

Arrowhead price target lowered to $38 from $51 at B. Riley
The FlyArrowhead price target lowered to $38 from $51 at B. Riley
8d ago
ARWR
IONS
Arrowhead Pharmaceuticals: Promising Pipeline Amidst Cautious Financial Outlook Warrants Hold Rating
PremiumRatings
Arrowhead Pharmaceuticals: Promising Pipeline Amidst Cautious Financial Outlook Warrants Hold Rating
9d ago
ARWR
Arrowhead Pharmaceuticals: Promising Drug Approval and Expanding Pipeline Justify Buy Rating
PremiumRatings
Arrowhead Pharmaceuticals: Promising Drug Approval and Expanding Pipeline Justify Buy Rating
9d ago
ARWR
Arrowhead Pharmaceuticals’ Earnings Call Highlights Growth and Challenges
PremiumCompany Announcements
Arrowhead Pharmaceuticals’ Earnings Call Highlights Growth and Challenges
10d ago
ARWR
Arrowhead Pharmaceuticals: Promising Pipeline and Strategic Developments Drive Buy Rating
PremiumRatings
Arrowhead Pharmaceuticals: Promising Pipeline and Strategic Developments Drive Buy Rating
11d ago
ARWR
Arrowhead Pharmaceuticals Reports Q1 2025 Financial Results
PremiumCompany AnnouncementsArrowhead Pharmaceuticals Reports Q1 2025 Financial Results
11d ago
ARWR
Arrowhead Pharmaceuticals: Strategic Licensing Deal and Upcoming Drug Launch Drive Buy Rating
Premium
Ratings
Arrowhead Pharmaceuticals: Strategic Licensing Deal and Upcoming Drug Launch Drive Buy Rating
11d ago
ARWR
Arrowhead reports Q1 EPS ($1.39), consensus (72c)
Premium
The Fly
Arrowhead reports Q1 EPS ($1.39), consensus (72c)
11d ago
ARWR
Arrowhead to receives $500M upfront in licensing pact with Sarepta
PremiumThe Fly
Arrowhead to receives $500M upfront in licensing pact with Sarepta
12d ago
ARWR
SRPT
Arrowhead Pharmaceuticals, Inc. (ARWR) Q1 Earnings Cheat Sheet
PremiumPre-Earnings
Arrowhead Pharmaceuticals, Inc. (ARWR) Q1 Earnings Cheat Sheet
14d ago
ARWR
Arrowhead Pharmaceuticals Appoints Douglas Ingram as Director
PremiumCompany Announcements
Arrowhead Pharmaceuticals Appoints Douglas Ingram as Director
15d ago
8K
ARWR
Genelux names Matthew Pulisic as CFO, effective January 30
PremiumThe Fly
Genelux names Matthew Pulisic as CFO, effective January 30
19d ago
ARWR
GNLX
Closing Bell Movers: Electronic Arts down over 10% on guidance cut
PremiumThe FlyClosing Bell Movers: Electronic Arts down over 10% on guidance cut
1M ago
AA
EA
Arrowhead up 4% at $20.51 after entry into S&P SmallCap 600 index
Premium
The Fly
Arrowhead up 4% at $20.51 after entry into S&P SmallCap 600 index
1M ago
ARWR
Arrowhead to replace Barnes Group in S&P 600 at open on 1/27
Premium
The Fly
Arrowhead to replace Barnes Group in S&P 600 at open on 1/27
1M ago
B
APO
Guidewire to replace Arrowhead in S&P 400 index at open on 1/27
PremiumThe Fly
Guidewire to replace Arrowhead in S&P 400 index at open on 1/27
1M ago
ARWR
GWRE
Arrowhead says FDA accepts NDA for investigational plozasiran
PremiumThe Fly
Arrowhead says FDA accepts NDA for investigational plozasiran
1M ago
ARWR
Sarepta’s Elevidys launch remains strong with solid beat, says JPMorgan
PremiumThe Fly
Sarepta’s Elevidys launch remains strong with solid beat, says JPMorgan
1M ago
ARWR
SRPT
Arrowhead doses 1st patients in study of ARO-INHBE for obesity treatment
PremiumThe Fly
Arrowhead doses 1st patients in study of ARO-INHBE for obesity treatment
2M ago
ARWR
Ionis FDA approval a positive for Arrowhead, says H.C. Wainwright
PremiumThe FlyIonis FDA approval a positive for Arrowhead, says H.C. Wainwright
2M ago
ARWR
IONS
Leadership Transition at Arrowhead Pharmaceuticals’ Board
Premium
Company Announcements
Leadership Transition at Arrowhead Pharmaceuticals’ Board
2M ago
8K
ARWR
Arrowhead announces interim results from ARO-CFB study
Premium
The Fly
Arrowhead announces interim results from ARO-CFB study
2M ago
ARWR

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >